TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainGlobeNewsWire • 12/28/20
TLC Announces Acceptance of Manuscript on Anti-COVID-19 Program by Clinical and Translational Science JournalGlobeNewsWire • 11/03/20
TLC Reports Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 10/28/20
TLC Announces the Appointment of Thomas H. Bliss, Jr., MBA, as Chief Business OfficerGlobeNewsWire • 10/21/20
TLC Enrolls First Subject in Phase I Clinical Trial of Inhalable Anti-COVID-19 Program (TLC19)GlobeNewsWire • 10/14/20
TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19GlobeNewsWire • 10/07/20
TLC to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech SummitGlobeNewsWire • 09/21/20
TLC to Present at HC Wainwright & Co. 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/09/20
TLC and 3SBio Announce Acceptance of Marketing Authorization Application for Ampholipad™ in ChinaGlobeNewsWire • 08/26/20
TLC Submits Investigational New Drug (IND) Application for TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19GlobeNewsWire • 08/14/20
TLC Reports Second Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 08/05/20
Manuscript Describes How TLC’s Inhalable Liposomal Hydroxychloroquine May Provide Clinical Benefit and Serve as Potential Treatment for COVID-19GlobeNewsWire • 07/15/20
TLC Announces Topline Results for TLC590 Phase II Trial for Postsurgical Pain Management following BunionectomyGlobeNewsWire • 05/31/20
TLC Highlights Findings in Abstract Accepted at Osteoarthritis Research Society International (OARSI) 2020 and Published in Osteoarthritis and CartilageGlobeNewsWire • 05/18/20
TLC Reports First Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 05/13/20
TLC Earns Highest Ranking in Corporate Governance Evaluation Six Years in a RowGlobeNewsWire • 05/04/20
TLC Announces Early Completion of Patient Enrollment in TLC590 Phase II Clinical Trial following BunionectomyGlobeNewsWire • 02/12/20
TLC Announces Dosing of First Patients in Part 2 of TLC590 Phase II Trial for Postsurgical Pain following BunionectomyGlobeNewsWire • 01/08/20
TLC Announces First Patient Enrollment in EXCELLENCE Trial Evaluating Single and Repeat Administrations of TLC599GlobeNewsWire • 11/27/19